Detalhe da pesquisa
1.
Alternative donor BMT with posttransplant cyclophosphamide as initial therapy for acquired severe aplastic anemia.
Blood
; 141(25): 3031-3038, 2023 06 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-37084383
2.
Bone marrow niche chemoprotection of metastatic solid tumors mediated by CYP3A4.
Cancer
; 129(11): 1744-1751, 2023 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36840972
3.
Clinical trial participation predicts improved survival in older adults receiving allogeneic blood and marrow transplant.
BMC Geriatr
; 23(1): 120, 2023 03 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36869287
4.
CD38 deletion of human primary NK cells eliminates daratumumab-induced fratricide and boosts their effector activity.
Blood
; 136(21): 2416-2427, 2020 11 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-32603414
5.
Safety and antibody response to two-dose SARS-CoV-2 messenger RNA vaccination in patients with multiple myeloma.
BMC Cancer
; 21(1): 1354, 2021 Dec 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-34961488
6.
Thrombotic Microangiopathy after Post-Transplantation Cyclophosphamide-Based Graft-versus-Host Disease Prophylaxis.
Biol Blood Marrow Transplant
; 26(12): 2306-2310, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-32961372
7.
Severe Cytokine Release Syndrome after Haploidentical Peripheral Blood Stem Cell Transplantation.
Biol Blood Marrow Transplant
; 25(12): 2431-2437, 2019 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-31394272
8.
Outpatient CD19-directed CAR T-cell therapy is feasible in patients of all ages.
Br J Haematol
; 203(4): 688-692, 2023 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37642134
9.
Major Histocompatibility Mismatch and Donor Choice for Second Allogeneic Bone Marrow Transplantation.
Biol Blood Marrow Transplant
; 23(11): 1887-1894, 2017 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-28754545
10.
Recipient clonal hematopoiesis in allogeneic bone marrow transplantation for lymphoid malignancies.
Blood Adv
; 2024 Apr 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-38640196
11.
CD38-Specific Gallium-68 Labeled Peptide Radiotracer Enables Pharmacodynamic Monitoring in Multiple Myeloma with PET.
Adv Sci (Weinh)
; 11(16): e2308617, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38421139
12.
Detection of an atypical BCR::ABL1 fusion in a patient with secondary B-cell acute lymphoblastic leukemia/lymphoma following multiple myeloma treatment.
Cancer Genet
; 274-275: 30-32, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-36966724
13.
A Gallium-68-Labeled Peptide Radiotracer For CD38-Targeted Imaging In Multiple Myeloma With PET.
bioRxiv
; 2023 Oct 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-37214794
14.
Allogeneic Blood or Marrow Transplantation with Post-Transplantation Cyclophosphamide for Peripheral T Cell Lymphoma: The Importance of Graft Source.
Transplant Cell Ther
; 29(4): 267.e1-267.e5, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36549386
15.
Allogeneic Blood or Marrow Transplantation with High-Dose Post-Transplantation Cyclophosphamide for Acute Lymphoblastic Leukemia in Patients Age ≥55 Years.
Transplant Cell Ther
; 29(3): 182.e1-182.e8, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36587740
16.
CD34+ cell of origin for immunoglobulin heavy chain variable region unmutated, but not mutated, chronic lymphocytic leukemia.
Leuk Lymphoma
; 63(7): 1617-1623, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35343368
17.
Nonmyeloablative Allogeneic Transplantation With Post-Transplant Cyclophosphamide for Acute Myeloid Leukemia With IDH Mutations: A Single Center Experience.
Clin Lymphoma Myeloma Leuk
; 22(4): 260-269, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-34750086
18.
Post-Transplantation Cyclophosphamide-Based Graft- versus-Host Disease Prophylaxis with Nonmyeloablative Conditioning for Blood or Marrow Transplantation for Myelofibrosis.
Transplant Cell Ther
; 28(5): 259.e1-259.e11, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35158092
19.
An Allogeneic Multiple Myeloma GM-CSF-Secreting Vaccine with Lenalidomide Induces Long-term Immunity and Durable Clinical Responses in Patients in Near Complete Remission.
Clin Cancer Res
; 27(24): 6696-6708, 2021 12 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-34667029
20.
Nonmyeloablative, HLA-Mismatched Unrelated Peripheral Blood Transplantation with High-Dose Post-Transplantation Cyclophosphamide.
Transplant Cell Ther
; 27(11): 909.e1-909.e6, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34425261